Nuwellis (NUWE) Sees Stock Surge Following QUELIMMUNE Treatment Announcement
Today, Nuwellis, Inc. (NASDAQ: NUWE) stock is seeing a significant increase following the announcement that the recently introduced QUELIMMUNE medication had successfully treated its first patient. The stock of NUWE was up 23.24% to $2.97 as of the most recent update. First Patient Treated with QUELIMMUNE Therapy Nuwellis announced that the inaugural patient received QUELIMMUNE […]